Alpha Tau Medical (DRTS) Preferred Stock Liabilities (2020 - 2026)

Alpha Tau Medical (DRTS) has reported Preferred Stock Liabilities for 7 consecutive years, with $15.7 million the latest figure, recorded in Q1 2026.

• Quarterly Preferred Stock Liabilities rose 344.23% year-over-year to $15.7 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $15.7 million (up 344.23% YoY) and the FY2025 annual result came in at $5.4 million, up 60.4% from the prior year.
• Preferred Stock Liabilities rose to $15.7 million in Q1 2026 per DRTS's latest filing, from $5.4 million in the prior quarter.
• Over the last five years, Preferred Stock Liabilities for DRTS reached as high as $15.7 million in Q1 2026 and fell as low as $53964.0 in Q1 2022.
• A 5-year average of $4.6 million and a median of $4.1 million in 2024 frame the typical range for Preferred Stock Liabilities.
• Annual changes were most pronounced in 2023 — Preferred Stock Liabilities jumped 14342.96% — and 2024, when it slumped 47.97%.
• Year by year, Preferred Stock Liabilities stood at $5.6 million in 2022, then slumped by 36.11% to $3.6 million in 2023, then retreated by 7.2% to $3.3 million in 2024, then surged by 60.4% to $5.4 million in 2025, then jumped by 194.14% to $15.7 million in 2026.
• According to Business Quant data, Preferred Stock Liabilities over the past three periods registered $15.7 million, $5.4 million, and $5.4 million for Q1 2026, Q4 2025, and Q3 2025 respectively.